Real-time enrollment status for this rheumatoid arthritis clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 5:16 AM UTC
| NCT Number | NCT06991114 |
| Recruiting Status | Recruiting |
| Condition | Rheumatoid Arthritis |
| Phase | PHASE2 |
| Target Enrollment | 90 participants |
| Active Locations | 31 sites in the US |
| Sponsor | Artiva Biotherapeutics, Inc. |
| Last Updated on CT.gov | May 22, 2026 (May 22, 2026) |
As of July 18, 2026: Clinical trial NCT06991114 is currently recruiting participants. This phase2 study for rheumatoid arthritis is actively seeking new participants at 31 locations across the United States. The study is sponsored by Artiva Biotherapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06991114 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 31 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06991114 was last updated May 22, 2026 (May 22, 2026). HelloStudys verifies this status automatically.